Tag Archives: EPO

UK National Stem Cell Network Report – The Patent Watch Landscape

Posted on March 7, 2013 by Warren Woessner

If you have either a passing or passionate interest in stem cell patenting, this report is worth some of your time. (A link to the report can be found at the end of this post.) The report analyzes the stem … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , | Leave a comment

Deposit of Biological Material – Impact on Validity of Priority Claim

Posted on March 1, 2013 by Warren Woessner

Please find linked below a guest post from Dr. Stefan Danner dealing with a new decision of the EPO Technical Boards of Appeal concerning the deposit of biological material. Biotech IP Newsletter  

Posted in Int'l Practice and Policy | Tagged , , , , , | Leave a comment

Common Patent for European Union Adopted

Posted on December 12, 2012 by Warren Woessner

The European Union has finally decided to adopt a common patent that will be granted in three languages – English, French and German – but will cover all of the 27 EU countries. Note that there is not a perfect … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , | Leave a comment

Admissibility of Disclaimers – New Lessons From The EPO Technical Boards of Appeal

Posted on August 23, 2012 by Warren Woessner

The following is a guest post from the 8/12 newsletter of Dr. Stefan Danner of DHS Patentanwaltsgesellschaft mbH.  Last year, the EPO Enlarged Board of Appeal (EBA) handed down its decision in case G2/10 relating to the admissibility of disclaimers whose … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment